The global objective of this Mentored Patient-Oriented Research Career Development Award is to promote the candidate's career as an academic physician-scientist and to facilitate her transition to an independent investigator. To accomplish this goal, the candidate and her mentors have developed an integrated plan that combines an innovative idea of great clinical significance, cutting-edge science and advanced training in the techniques of patient-oriented research. LIT Southwestern provides a great infrastructure and an excellent academic environment to support the career development of young clinical investigators. This award will provide the candidate with the time, resources, and skills necessary for clinical and translational research in the field of diabetes. The proposed research plan will test if the lipotoxicity mechanism is a significant contributor to beta-cell dysfunction in humans. It is hypothesized that pancreatic triglyceride (fat) accumulation contributes to betacell failure and the development of type 2 diabetes. The relationship between ectopic fat acumulation in the pancreas and beta-cell function will be determined in Aim 1.
In Aim 2 subjects planning to undergo bariatric surgery will be evaluated and followed for 1 year after the procedure. Changes in pancreatic fat content, beta-cell function, and insulin resistance will be described.
The third Aim will assess if a drug intervention (pioglitazone) will reduce fat accumulation in the pancreas alongside with improvement of beta-cell function. A novel non-invasive magnetic resonance spectroscopy technique will be used to accurately and reliably quantify pancreatic fat content. Improved understanding of the pathophysiology of type 2 diabetes will aid the development of effective agents for diabetes prevention and even cure. Since type 2 diabetes has become so prevalent and is associated with high morbidity and mortality, such work has significant public health impact. Also, if pancreatic fat quantification proves to be a good predictor of beta-cell function, this novel non-invasive test could develop into a valuable clinical tool used to accurately predict the development of diabetes in high-risk subjects. The combination of advanced training in patient-oriented research and in-depth study of an important clinical problem will prepare the candidate for a Iong-term career as an independent investigator.

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
Mentored Patient-Oriented Research Career Development Award (K23)
Project #
5K23RR024470-03
Application #
7649415
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Program Officer
Wilde, David B
Project Start
2007-09-30
Project End
2012-07-31
Budget Start
2009-08-01
Budget End
2010-07-31
Support Year
3
Fiscal Year
2009
Total Cost
$151,200
Indirect Cost
Name
University of Texas Sw Medical Center Dallas
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800771545
City
Dallas
State
TX
Country
United States
Zip Code
75390
Pop, Laurentiu M; Mari, Andrea; Zhao, Tong-Jin et al. (2018) Roux-en-Y gastric bypass compared with equivalent diet restriction: Mechanistic insights into diabetes remission. Diabetes Obes Metab 20:1710-1721
Tanigaki, Keiji; Sacharidou, Anastasia; Peng, Jun et al. (2018) Hyposialylated IgG activates endothelial IgG receptor Fc?RIIB to promote obesity-induced insulin resistance. J Clin Invest 128:309-322
Harrison, Lindsay B; Adams-Huet, Beverley; Li, Xilong et al. (2014) Intensive therapy in newly diagnosed type 2 diabetes: results of a 6-year randomized trial. J Investig Med 62:676-86
Lingvay, Ildiko; Guth, Eve; Islam, Arsalla et al. (2013) Rapid improvement in diabetes after gastric bypass surgery: is it the diet or surgery? Diabetes Care 36:2741-7
Harrison, Lindsay B; Adams-Huet, Beverley; Raskin, Philip et al. (2012) ?-cell function preservation after 3.5 years of intensive diabetes therapy. Diabetes Care 35:1406-12
Lingvay, Ildiko; Roe, Erin D; Duong, Jonathan et al. (2012) Effect of insulin versus triple oral therapy on the progression of hepatic steatosis in type 2 diabetes. J Investig Med 60:1059-63
Szczepaniak, Lidia S; Victor, Ronald G; Mathur, Ruchi et al. (2012) Pancreatic steatosis and its relationship to ?-cell dysfunction in humans: racial and ethnic variations. Diabetes Care 35:2377-83
Richard, John; Lingvay, Ildiko (2011) Hepatic steatosis and Type 2 diabetes: current and future treatment considerations. Expert Rev Cardiovasc Ther 9:321-8
Lingvay, Ildiko; Esser, Victoria; Legendre, Jaime L et al. (2009) Noninvasive quantification of pancreatic fat in humans. J Clin Endocrinol Metab 94:4070-6